Whole foods can also have appetite-suppressant effects of the popular medication, triggering gut cells to release GLP-1 when consumed
Because this is an area with notable unmet needs, especially in terms of pharmacological treatment options, further research investment is warranted
The subsections below delineate probable advantages, dangers, and pragmatic factors for males and females individually, then conclude with anticipated returns
First injection: severe redness, significant itching, 72+ hours Second injection: same or worse Third injection: same or worse Long-term outcome: requires intervention (technique optimization, antihistamines, or provider evaluation) The three-injection rule helps set expectations
Retatrutide weight loss results: Phase 2 vs Phase 3 TRIUMPH-4 trial data Phase 3: TRIUMPH-4 Results (December 2025) In December 2025, Eli Lilly announced topline results from TRIUMPH-4, the first completed Phase 3 trial for retatrutide